Proteocyte AI

12/19/2025

📄 What’s included in a STRATICYTE® report?

STRATICYTE® is supported by over a decade of clinical research and robust clinical validation which continues to be strengthened by ongoing studies with major oral pathology centres in North America.

Each STRATICYTE® report provides:

✔️ A personalized 5-year cancer risk score
✔️ Clear classification of low vs. elevated risk

This comprehensive insight helps clinicians confidently manage oral precancer patients with evidence-based precision.

👉 Watch this short video to learn about this novel test: https://www.youtube.com/watch?v=m7boEYIsQpk

Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer de recherche sur le cancer / Cancer Research Society québécoise du cancer Dental Association Dental Society and Labrador Dental Association Scotia Dental Association Dental Association Society of Oral and Maxillofacial Surgery The Terry Fox Foundation The Princess Margaret Cancer Foundation Academy of Otolaryngology—Head and Neck Surgery Academy of Oral Medicine Academy of Oral and Maxillofacial Pathology - AAOMP Association of Oral and Maxillofacial Surgeons - AAOMS American Cancer Society American Dental Association Oral & Maxillofacial Surgeons Oral Surgery Head and Neck Cancer Alliance Science Foundation Oral Cancer Foundation Oral Health Jaw Surgery of OMS Administrators SPOHNC Mouth Cancer Foundation Foundation Oral Health Foundation Events

12/16/2025

Heather discovered an oral lesion. In this video, Heather reveals what happened next and how STRATICYTE® helped shape her course of treatment and future care decisions.

As a patient/family member of a patient STRATICYTE® brings
✅ Peace of Mind: Timely, accurate results
✅ Clarity: Early diagnosis for optimal treatment and outcomes
✅ A Path Forward: Patient empowerment, Informed decision-making

Learn more: https://proteocyte.com/straticyte/patients/

Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer de recherche sur le cancer / Cancer Research Society québécoise du cancer Dental Association Dental Society and Labrador Dental Association Scotia Dental Association Dental Association Society of Oral and Maxillofacial Surgery The Terry Fox Foundation Princess Margaret Cancer Foundation Academy of Otolaryngology—Head and Neck Surgery Academy of Oral Medicine Academy of Oral and Maxillofacial Pathology - AAOMP Association of Oral and Maxillofacial Surgeons - AAOMS American Cancer Society American Dental Association Oral & Maxillofacial Surgeons Oral Surgery Head and Neck Cancer Alliance Science Foundation Oral Cancer Foundation Oral Health Jaw Surgery of OMS Administrators SPOHNC Mouth Cancer Foundation Foundation Oral Health Foundation Events

12/12/2025

For a limited time, get expanded access to our exclusive test, STRATICYTE® through the 2025

PAISIP (Proteocyte AI Shared Innovation Program)
Order STRATICYTE® at https://proteocyte.com/ordering-options/

Get early OSCC prediction
Give patients a 5-year window to OSCC risk

Our Offer: Increase OSCC detection + prediction. Proactively manage OPMD patients
Our Ask: Order the test and share feedback on the process, the report, and its utility

Together, we can improve OPMD patient care and outcomes

Order STRATICYTE® at https://proteocyte.com/ordering-options/

LEARN MORE: watch our intro on “What is STRATICYTE and how can it help?”
https://www.youtube.com/watch?v=m7boEYIsQpk

Email clientservices@proteocyte.com for more info

Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer de recherche sur le cancer / Cancer Research Society québécoise du cancer Dental Association Dental Society and Labrador Dental Association Scotia Dental Association Dental Association Society of Oral and Maxillofacial Surgery The Terry Fox Foundation Princess Margaret Cancer Foundation Academy of Otolaryngology—Head and Neck Surgery Academy of Oral Medicine Academy of Oral and Maxillofacial Pathology - AAOMP Cancer Society Dental Association Oral & Maxillofacial Surgeons Oral Surgery and Neck Cancer Alliance Science Foundation Cancer Foundation Oral Health Jaw Surgery of OMS Administrators SPOHNC Mouth Cancer Foundation Foundation Oral Health Foundation

12/11/2025

STRATICYTE® is the only objective test that can distinguish oral lesions at elevated risk of becoming cancerous from those with little to no risk. Built on over a decade of clinical research and robust clinical validation, STRATICYTE® empowers clinicians to personalize patient management and support better outcomes.

🧬 How do I order STRATICYTE®?

Ordering STRATICYTE®easily integrates into your existing workflow.

Simply:
1️⃣ Go to our website
2️⃣ Download the Test Request Form
3️⃣ Proteocyte AI does the rest!

👉 Learn more about the ordering process at https://proteocyte.com/ordering-options/

Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer de recherche sur le cancer / Cancer Research Society québécoise du cancer Dental Association Dental Society and Labrador Dental Association Scotia Dental Association Dental Association Society of Oral and Maxillofacial Surgery The Terry Fox Foundation Princess Margaret Cancer Foundation Academy of Otolaryngology—Head and Neck Surgery Academy of Oral Medicine Academy of Oral and Maxillofacial Pathology - AAOMP Association of Oral and Maxillofacial Surgeons - AAOMS Cancer Society Dental Association Oral & Maxillofacial Surgeons Oral Surgery and Neck Cancer Alliance Science Foundation Oral Cancer Foundation Oral Health Jaw Surgery of OMS Administrators SPOHNC Mouth Cancer Foundation Foundation Oral Health Foundation Events

12/04/2025

Proteocyte AI is on a mission to increase early oral cancer detection and prediction, and decrease oral cancer fatalities, through expanded access to our exclusive test:

For a limited time, Proteocyte AI is offering expanded access to their exclusive OSCC prognostic, STRATICYTE® test through the PAISIP (Proteocyte AI Shared Innovation Program).

Built on extensive precancer research, Proteocyte AI knows diagnosing oral potentially malignant disease (OPMD) is complex, and lack of precise risk stratification can lead to disease progression and higher costs. Proteocyte AI is on a mission to change that – enabling earlier, proactive management of oral precancer patients.

Proteocyte AI’s PAISIP fosters vital scientific collaboration & clinical experience through STRATICYTE® – your 5-year window to oral cancer risk.

Our Offer: increase early OSCC detection and prediction to enable earlier, more proactive management of oral precancer patients

Our Ask: order STRATICYTE ®, share feedback with our Client Services team regarding the process, resulting report, and clinical utility

Our Role: Client Services provides end-to-end support for a seamless process

To order STRATICYTE®, visit: https://proteocyte.com/ordering-options/

Together, we can improve OPMD patient care and outcomes.

Learn how Proteocyte AI’s PAISIP works for you to help patients live better, longer: https://proteocyte.com/about/contact/

Watch "What is STRATICYTE and how can it help?": https://youtu.be/m7boEYIsQpk?si=T2Xu4NmRtVlRjdIY

, des chirurgiens dentistes du Québec - ACDQ , Cancer Foundation , Dental Association , Care Manitoba , Association of Oral and Maxillofacial Surgeons , Cancer Society , Dental Association , Partnership Against Cancer , Research Society , québécoise du cancer , Dental Association , Brunswick Dental Society , and Labrador Dental Association , Scotia Dental Association , Dental Association (ODA) , Society of Oral & Maxillofacial Surgeons , Fox Foundation , Princess Margaret Cancer Foundation , Academy of Otolaryngology , ACADEMY OF ORAL MEDICINE , Academy of Oral and Maxillofacial Pathology , Association of Oral and Maxillofacial Surgeons , Cancer Society , Dental Association , Oral & Maxillofacial Surgeons , Oral Surgery , & Neck Cancer Alliance , Science Foundation , Cancer Foundation , Oral Health , Jaw Surgery , of OMS Administrators , For People With Oral And Head And Neck Cancer (SPOHNC) Cancer Foundation , Foundation , Health Foundation , events

A test that assesses the risk of trasformation of an oral pre-malignant lesion to invasive oral cancer.

11/26/2025

What are the cost considerations and reimbursement pathways associated with adopting Straticyte?

Adopting innovative diagnostics often raises questions about financial feasibility. Here’s what clinicians need to know:
✔️ STRATICYTE™ can help reduce long-term healthcare costs by preventing late-stage oral cancer
✔️ By enabling earlier intervention, it lowers the need for more intensive, costly treatments
✔️ Reimbursement pathways are emerging as predictive diagnostics gain recognition in clinical practice

In short: investing in STRATICYTE™ not only supports better patient outcomes but also contributes to more sustainable healthcare.

➡️ Watch the video: https://proteocyte.com/video-gallery/

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , American Academy of Oral Medicine , American Academy of Oral and Maxillofacial Pathology - AAOMP , Canadian Dental Association , Canadian Association of Oral and Maxillofacial Surgeons , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association , SurgeOn Events

11/20/2025

Thank you to everyone who joined the AAOM Educational Webinar: AI and Biomarker-Guided Diagnostics in Oral Lesions: From Risk Stratification to Clinical Pathways.

An excellent CE event with valuable insights shared by 2 experts in their respective fields; Dr. Paras Patel, Oral and Maxillofacial PathologistDirector of the Oral Maxillofacial Pathology Department at Propath, Dallas, TX and Dr. Waleed Zaid, Professor, Fellowship Director, Head and Neck Oncology and Microvascular Surgery, LSU Health New Orleans

Couldn’t make it live? You can view the recording and learn more about Proteocyte AI and the role of prognostic tools in oral cancer risk assessment here: https://vimeo.com/1134602267?share=copy

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , American Academy of Oral Medicine , American Academy of Oral and Maxillofacial Pathology - AAOMP , Canadian Dental Association , Canadian Association of Oral and Maxillofacial Surgeons , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association , SurgeOn Events

11/18/2025

Get to know the Proteocyte team!

Meet our Principal Scientist & Lab Manager, Jason Hwang. Jason is fluent in the field of cell differentiation/signaling and cancer metastasis, with over 10 years of research lab experience. He has overseen multiple research projects including the supervision of graduate/undergraduate students and other lab members, and is the co-inventor of Proteocyte’s first patent for the automated method for assessing oral cancer risk progression. He obtained his HBSc in Cell biology, and his MSc and PhD in Cell & Developmental Biology from The University of Western Ontario in London, Ontario.

“Advances in protein biomarker-based computational analysis are driving the adoption of digital pathology and machine learning–based diagnostics across modern healthcare. Proteocyte’s flagship product, Straticyte, utilizes high-resolution whole-slide imaging and advanced AI analysis to deliver individualized, quantitative, and reproducible assessments of oral cancer transformation risk—enhancing and complementing traditional histopathology. Having been part of Proteocyte's journey over the past decade and finally seeing this innovation take flight has been an incredibly rewarding experience."

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , American Academy of Oral Medicine , American Academy of Oral and Maxillofacial Pathology - AAOMP , Canadian Dental Association , Canadian Association of Oral and Maxillofacial Surgeons , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association , SurgeOn Events

11/12/2025

Why should oral healthcare providers involved in the detection and treatment of oral cancer take interest in STRATICYTE ?

Early detection and early prediction is critical in oral cancer care — but traditional histopathology has limits in predicting which lesions may progress.

STRATICYTE™ provides a personalized risk score that helps clinicians:
✔️ Identify LOW risk and AT risk cases with greater accuracy
✔️ Intervene earlier for better outcomes
✔️ Improve patient communication and compliance with follow-up

By supporting more informed decision-making, STRATICYTE™ represents an important advancement in the fight against oral cancer.

➡️ Watch the video: https://proteocyte.com/video-gallery/
✅ To order the STRATICYTE test or to learn more: https://proteocyte.com/ordering-options/

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , American Academy of Oral Medicine , American Academy of Oral and Maxillofacial Pathology - AAOMP , Canadian Dental Association , Canadian Association of Oral and Maxillofacial Surgeons , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association , SurgeOn Events

11/04/2025

⏳ Just 2 Days Away!

Join us Thursday, November 6 at 7 PM ET for the AAOM Educational Webinar: AI and Biomarker-Guided Diagnostics in Oral Lesions: From Risk Stratification to Clinical Pathways

Hosted by AAOM and proudly sponsored by Proteocyte AI, this session will feature Drs. Paras Patel and Waleed Zaid, who will discuss how AI and biomarker-guided tools—like STRATICYTE™—are shaping the future of oral cancer diagnostics.

🎓 Earn 1 CE credit
📅 November 6 | 7–8 PM ET
🔗 Register now: https://www.aaom.com/webinars
✅ To order the STRATICYTE test or to learn more: https://proteocyte.com/ordering-options/

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , American Academy of Oral Medicine , American Academy of Oral and Maxillofacial Pathology - AAOMP , Canadian Dental Association , Canadian Association of Oral and Maxillofacial Surgeons , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association , SurgeOn Events

11/01/2025

✨November is Mouth Cancer Action Month

💡 Did you know?*
• Worldwide mouth cancer affects 650,000 people per year
• Incidence of mouth cancer have risen by 49% over the past 10 years
• 78% of cases occur in people over the age of 55
• 53% of all mouth cancers are diagnosed at stage IV

Proteocyte AI is transforming cancer risk prediction with advanced biomarker analysis and digital pathology. Our flagship product, STRATICYTE™, empowers healthcare professionals to identify oral cancer risk early, supporting personalized treatment plans and improved patient outcomes.
STRATICYTE™ represents an important advancement in the fight against oral cancer by supporting more informed decision-making.

✅ To order the STRATICYTE test or to learn more: https://proteocyte.com/ordering-options/
Mouth Cancer Action Month is held in November every year and is supported by the Cancer Foundation and the Health Foundation.

References: *https://www.mouthcancerfoundation.org/mouth-cancer-facts-and-figures/

Dental Association , Association of Oral and Maxillofacial Surgeons-AAOMS, , , , , , ™, Academy of Otolaryngology—Head and Neck Surgery , American Dental Association

10/30/2025

Proteocyte Team Member Spotlight – Dr. Barrie Renick

Get to know the Proteocyte team!

Meet Proteocyte’s Chief Medical Officer for Canada, Dr. Barrie Renick. Dr. Renick has a broad-based oral surgery practice but an interest in dental cysts and tumours but particularly mucosal disease. He has been in private practice in Newmarket and a Staff surgeon at Southlake Hospital for over 30 years. He has dual specialty training in both oral surgery and oral pathology. His training included experience at Toronto General and Toronto Western Hospitals, The Wellesley Hospital, Sick Kids, Sunnybrook Hospital, Odette Cancer Clinic, Princess Margaret Hospital, and the both the Sunnybrook and UHN Interdisciplinary Mouth Clinics.

“For the first 20+ years of my practice I struggled with the management of oral precancer or oral potential malignant disease (OPMD) patients. Some developed cancer. Some did not. It was a real guessing game, making patient management extremely difficult. The Straticyte test ended the speculation. Using the Straticyte test I could finally, correctly identify, the high risk OPMD patient, and confidently develop an appropriate treatment plan. The guessing was over. I was so impressed with the performance of the Straticyte test, I joined the Proteocyte team to educate my colleagues on how Straticyte could revolutionize care of their patients.”

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , American Academy of Oral Medicine , American Academy of Oral and Maxillofacial Pathology - AAOMP , Canadian Dental Association , Canadian Association of Oral and Maxillofacial Surgeons , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association , SurgeOn Events